Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C

Psychiatric and substance use disorders affect most patients with chronic hepatitis C and are the most common reasons for exclusion from antiviral therapies. Suicidal ideation (SI) is often cited as a reason to exclude patients from interferon-based treatment or to terminate antiviral treatment that...

Full description

Saved in:
Bibliographic Details
Published inGeneral hospital psychiatry Vol. 26; no. 3; pp. 237 - 240
Main Authors Dieperink, Eric, Ho, Samuel B., Tetrick, Lori, Thuras, Paul, Dua, Kulwinder, Willenbring, Mark L.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.05.2004
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Psychiatric and substance use disorders affect most patients with chronic hepatitis C and are the most common reasons for exclusion from antiviral therapies. Suicidal ideation (SI) is often cited as a reason to exclude patients from interferon-based treatment or to terminate antiviral treatment that is in progress. This study examines SI in hepatitis C patients untreated and treated with interferon-α2b, a medication commonly associated with depression. Fifty-five subjects with chronic hepatitis C were followed for 24 weeks with three measures of depression, each containing one item assessing SI. A total of 15/55 (27%) subjects reported SI while not on interferon therapy. Of the 42 patients treated with interferon, 18 (43%) endorsed SI at some point during antiviral treatment. However, 17/18 (94%) finished at least a 6-month course of interferon therapy. No subjects attempted suicide. Although SI in some form is common in hepatitis C patients, in most cases it is mild in nature. With adequate support most patients can successfully complete a full course of antiviral treatment.
ISSN:0163-8343
1873-7714
DOI:10.1016/j.genhosppsych.2004.01.003